2025-10-03 - Analysis Report
Okay, here's the analysis of Hims & Hers Health Inc. (HIMS), incorporating all the provided information. The report is in English, with key figures highlighted and analysis following.

**Report on Hims & Hers Health Inc. (HIMS)**

**0. Overview**

*   **Ticker:** HIMS
*   **Company Name:** Hims & Hers Health Inc.
*   **Description:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions.

**1. Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 277.48%
*   **VOO Cumulative Return:** 71.52%
*   **Absolute Spread:** 206.0
*   **Relative Spread:** 71.7 (This indicates the current spread is in the 71.7th percentile of its historical range).
*   **Interpretation:** HIMS has significantly outperformed the S&P 500 (VOO) over the period covered by the data.  The relative spread suggests that while HIMS is performing well compared to VOO, there is still room for potential movement within its historical performance range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2019-2021  | -42.0%  | 74.4% | -81.0%  | 0.0   | 1.5    |
| 2020-2022  | -19.0%  | 78.6% | -18.0%  | -0.0  | 1.4    |
| 2021-2023  | -65.0%  | 78.6% | -67.0%  | -0.1  | 2.0    |
| 2022-2024  | 119.0% | 79.4% | 98.0%  | -0.0  | 5.4    |
| 2023-2025  | 282.0% | 80.8% | 220.0% | 0.1   | 12.7   |

*   **Analysis:** The provided table shows a fluctuating performance for HIMS.
    *   **CAGR:** The Compound Annual Growth Rate (CAGR) varies significantly, showing periods of substantial losses followed by impressive gains. The 2023-2025 period has a very high CAGR of 282.0%.
    *   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant volatility and risk.
    *   **Alpha:** Alpha fluctuates considerably. The recent period (2023-2025) shows a very high positive alpha, indicating strong outperformance relative to its risk.
    *   **Beta:** Beta is relatively low (around 0), suggesting that HIMS's price movements are not strongly correlated with the market (S&P 500).
    *   **Cap(B):** The company's market capitalization has grown significantly over the period, indicating increased investor confidence and/or company expansion.

**2. Recent Stock Price Movement**

*   **Current Price:** 57.005
*   **Last Market Data:**
    *   Price: 57.87
    *   Previous Close: 56.31
    *   Change: 2.77 (Significant Positive Change)
*   **5-Day Moving Average:** 55.4829
*   **20-Day Moving Average:** 52.1402
*   **60-Day Moving Average:** 51.3087

*   **Analysis:** The stock is trading above all its moving averages, indicating an uptrend.  The significant positive change in the last market data (change: 2.77) suggests a recent upward price surge.

**3. Technical Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 64.64 (Approaching Overbought territory but not yet there)
*   **PPO:** 1.092 (Positive, indicating the short-term moving average is above the long-term moving average)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (3492 shares - Very Safe - MRI:0.90)
*   **Recent Relative Spread Change (20-day):** -0.8 (Negative, indicating short-term decrease in relative spread)
*   **Expected Return:** 1.2% (Indicates expected outperformance vs. S&P 500 over the long term)

*   **Analysis:**
    *   The high MRI suggests the stock is currently considered a relatively safe investment, according to this indicator.
    *   The RSI indicates that the stock is approaching overbought conditions, which might signal a potential pullback.
    *   The positive PPO confirms the current uptrend.
    *   The Hybrid Signal is a strong buy signal, based on the MRI and other factors.
    *   The slight decrease in relative spread, indicates HIMS has pulled back slightly compared to the S&P 500 recently.
    *   The expected return suggests that long-term, HIMS is expected to outperform the S&P 500.

**4. Recent News & Significant Events (Yahoo Finance)**

*   **[2025-10-02]** Breakout Stocks Watch: What Looms For October? (Investor's Business Daily) - *Indicates HIMS is being considered as a potential breakout stock.*
*   **[2025-10-02]** agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know (StockStory) - *Highlights positive trading activity for HIMS and its peers.*
*   **[2025-10-01]** OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks) - *Implies that HIMS is being evaluated as a value stock.*
*   **[2025-10-01]** The Secret to Finding the Next Amazon Is Hiding in Plain Sight (Motley Fool) - *Suggests HIMS has significant growth potential.*
*   **[2025-10-01]** HIMS: Raising target price to $48.00 (Argus Research) - *A positive signal indicating analyst confidence.*
*   **[2025-09-30]** Hims & Hers Health Insider Sold Shares Worth $5,116,924, According to a Recent SEC Filing (MT Newswires) - *Insider selling can sometimes raise concerns, but needs to be viewed in context (e.g., profit-taking after a significant gain).*

**4-2. Analyst Opinions**

*   **Consensus:** Hold (2.92)
*   **Target Price:**
    *   Average: 47.42
    *   High: 85.00
    *   Low: 25.00
*   **Recent Rating Changes:** (No changes available in the provided data)

*   **Analysis:**  The analyst consensus is "Hold," suggesting a neutral outlook.  The average target price of $47.42 is below the current price, which is a bearish signal. However, the high target price of $85.00 shows that some analysts are very optimistic about the stock's potential.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-08-04 | 0.19 | 0.54 B$  |
| 2025-05-05 | 0.22 | 0.59 B$  |
| 2024-11-04 | 0.35 | 0.40 B$  |
| 2024-08-05 | 0.06 | 0.32 B$  |
| 2025-08-04 | 0.06 | 0.32 B$  |

*   **Analysis:**
    *   **EPS:** Fluctuating EPS values make it hard to establish a clear trend.
    *   **Revenue:** Revenue shows a general upward trend over the past quarters.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $0.54B   | 76.39%        |
| 2025-03-31   | $0.59B   | 73.50%        |
| 2024-12-31   | $0.48B   | 76.81%        |
| 2024-09-30   | $0.40B   | 79.16%        |
| 2024-06-30   | $0.32B   | 81.30%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE    |
|--------------|----------|--------|
| 2025-06-30   | $0.56B   | 7.55%  |
| 2025-03-31   | $0.55B   | 9.01%  |
| 2024-12-31   | $0.48B   | 5.46%  |
| 2024-09-30   | $0.44B   | 17.18% |
| 2024-06-30   | $0.36B   | 3.67%  |

*   **Analysis:**
    *   **Revenue:**  Consistent revenue growth is observed over the quarters.
    *   **Profit Margin:** Profit margins are consistently high, indicating strong operational efficiency.
    *   **Equity:**  Equity is increasing, suggesting a strengthening financial position.
    *   **ROE:** ROE is volatile but generally positive, indicating profitability relative to equity.

**7. Overall Summary**

Hims & Hers Health Inc. (HIMS) presents a mixed but potentially promising picture.

*   **Strengths:**
    *   Significant outperformance against the S&P 500 historically.
    *   Strong revenue growth and high-profit margins.
    *   Positive technical indicators (PPO, MRI).
    *   Bullish news headlines suggest growth potential and analyst upgrades.
*   **Weaknesses/Risks:**
    *   High historical volatility (MDD).
    *   Analyst consensus is "Hold" with an average target price below the current market price.
    *   Recent insider selling, though context is important.
    *   Fluctuating EPS values.
*   **Outlook:** The company appears to be in a growth phase, but with inherent risks.  The recent price surge and positive news flow suggest positive momentum. However, investors should be aware of the volatility and analyst concerns before making investment decisions. The recommendation would be to **monitor the stock closely**, paying attention to future earnings reports, analyst updates, and any further insider activity. A small, well-considered position might be appropriate for investors with a high-risk tolerance and a long-term investment horizon.
